LivaNova is a global medical technology company built on nearly five decades of experience and a relentless commitment to improve the lives of patients around the world. Our advanced technologies and breakthrough treatments provide meaningful solutions for the benefit of patients, healthcare professionals and healthcare systems.
At LivaNova, we understand the importance of bringing both clinical and economic value to our customers. We are a strong, market-leading medical technology and services company, offering a diverse product portfolio and global reach. LivaNova is listed on the NASDAQ stock exchange under the ticker symbol “LIVN.”
We are headquartered in London (UK) and maintain a presence in more than 100 countries. LivaNova operates as three business franchises:
• Cardiac Surgeries
• Cardiac Rhythm Management
Medtronic began its operations in India in the year 1979. With over 1100 employees, India Medtronic Pvt. Ltd. is a wholly-owned subsidiary of Medtronic Plc. It is headquartered at Solitaire Corporate Park in Mumbai and has its oﬃces at Ahmedabad, Bangalore, Chennai, Cochin, Dhaka, Gurgaon, Hyderabad, Kolkata, New Delhi, Pune and Vadodara and Colombo.
Our businesses primarily fall into four groups: the Cardiac and Vascular Group (CVG), the Restorative Therapies Group (RTG), the Diabetes Group and the Minimally Invasive Therapies Group (MITG). The Cardiac and Vascular Group encompasses Cardiac Rhythm and Heart Failure (CRHF), Coronary, Structural Heart and Arterial and Peripheral Vascular businesses; the Restorative Therapies Group includes Spine and Biologics, Surgical Technologies, Neuromodulation and Neurovascular businesses; the Diabetes Group oﬀers Insulin Pump Therapy and Continuous Glucose Monitoring Systems (CGMS) and the Minimally Invasive Therapies group comprises of Early Technologies, Advanced Surgical Technologies and General Surgical Products, and Medical Supplies, Respiratory and Monitoring Solutions, and Venous Solutions.
India Medtronic has two Research and Development (R&D) centers, in Bangalore and Hyderabad respectively. The Medtronic India Development Centre (MIDC) – the R&D facility at Bangalore develops the key aspects of Medtronic’s renal care solutions business and the Medtronic Engineering and Innovation Center (MEIC) at Hyderabad provides high quality, cost eﬀective engineering services to Medtronic’s Minimally Invasive Therapies Group (MITG) businesses’ global and regional business units.
Mölnlycke Health Care is a world-leading medical products and solutions company that equips healthcare professionals to achieve the best patient, clinical and economic outcomes. We design and supply products and solutions for use in wound treatment, pressure ulcer, infection prevention and surgery. Our products and solutions provide value for money supported by clinical and health economic evidence.
Olympus Medical Systems India Private Limited commenced its Direct business operation in India from April 1, 2010 with an initial objective to become the most respected, reliable and chosen Brand in healthcare domain in India. Olympus Medical Systems India is a wholly owned subsidiary of Olympus Corporation of Asia Pacific Ltd and have major manufacturing foot prints at Japan and Germany. Through a focussed approach in the market, Olympus has been able to develop a great relationship and visible presence across full spectrum of customer base includes prime education institutes and corporate hospitals in India.
Olympus has a wide portfolio of products that are equipped with the latest innovative and superior technology. Olympus deals primarily in two verticals i.e. Gastrointestinal/ Respiration & Surgical divisions and contribute to the medical society with state of the art product categories that includes, Video Endoscopy, Endoscopic Ultrasound, Bronchoscopy, Endotherapy devices in Gastrointestinal & Respiratory range whereas Surgical division includes High definition imaging system includes 3D & 4K system with high end Energy products to deal with Laproscopy, Genaral surgery, Gynecology and urology field.
OLYMPUS is primarily involved in supporting various training activities to spread awareness among Indian users through its strong marketing team and is committed to continue to participate in such events in future as well.
Olympus has been spending heavily and expanding its sales and service network through state of the art National Service Workshops at Head Office Gurgaon and 8 more locations – qualifying the most stringent protocols followed at Japan, covering the vast geography of India. Olympus has been growing rapidly in India and is committed to dedicate all required sales, service and marketing resources for further growth in such a vibrant emerging market.
Smith & Nephew Healthcare
As a 160 years old UK-headquartered medical devices manufacturer and multinational organization, Smith & Nephew supports healthcare professionals in more than 100 countries in their daily efforts to improve the lives of their patients.
We are one of the global leaders in:
- Orthopaedics Reconstruction – joint replacement systems for knees, hips and shoulders
- Advanced Wound Management – wound care treatment and prevention products used to treat hard-to-heal wounds
- Sports Medicine – minimally invasive surgery of the joints
- Trauma & Extremities – products that help repair fractures and deformities
With our annual sales of close to 4.6 billion USD (2015), we have around 15,000 employees around the world, who embody Innovation, Trust and Performance as the core values of Smith & Nephew.
We are a constituent of the UK’s FTSE100 and our shares are traded on the London Stock Exchange and through American Depository Receipts on the New York Stock Exchange.
Smith & Nephew has frequently made it to the Forbes’ list of the World’s 100 Most Innovative Companies (2013, 2015, 2016).
Smith & Nephew takes a pioneering approach to the design of our advanced medical products and services, by securing wider access to our diverse technologies for more customers globally, and by enabling better outcomes for patients and healthcare systems. Our recent initiatives include the launch of our mid-tier value segment of products in orthopedics and wound management (which includes the legacy range of our acquired Sushrut-Adler business in India), acquisitions of Arthrocare (to strengthen our performance in Sports Medicine) and Blue Belt Technologies (giving us a leading position in the fast-growing area of robotics-assisted orthopaedic surgery). In addition, we make major investments in R&D as well as Educational platforms and Evidence generation, which have been our major drivers in India and emerging markets, where providing affordable quality healthcare, training and product and business model innovations are the key to growth.
A testament to the positive difference that we have made is our recent recognition (2016) by the Economic Times as one of the Best Healthcare Brands in India.